Scholarlink

Purpose <p>Pontine diffuse midline gliomas (PDMGs) are among the most lethal pediatric brain tumors with a median survival of approximately one year. Reliable prognostic markers are needed to guide treatment strategies and inform families. Our study aims to investigate the prognostic utility of delta-radiomic features in PDMGs.</p> Materials and methods <p>We retrospectively analyzed 35 pediatric patients with PDMG diagnosed between 2012 and 2020, all treated with radiotherapy plus concomitant and adjuvant temozolomide. Pre- and post-treatment MRI (T1-weighted, T2-weighted, and ADC maps) were subjected to manual segmentation and texture feature extraction using MaZda software. Delta radiomics features were calculated as ratios between post- and pre-treatment values. Diagnostic performance for predicting survival below or above 12 months was assessed using ROC analysis, while overall survival was further evaluated with Kaplan–Meier and Cox regression models.</p> Results <p>Median overall survival was 13 months (range: 6–69). Among baseline features, only sum average from non-contrast T1 was significant, with lower values (indicating higher heterogeneity) associated with shorter OS. In the post-radiotherapy setting, sum entropy from T1 images emerged as an independent prognostic predictor, with higher values correlating with longer OS. Delta radiomics parameters, particularly sum entropy derived from T1 and T2 sequences, yielded higher AUC values than single post-treatment features, suggesting superior prognostic accuracy.</p> Conclusion <p>Our preliminary results indicate that delta-radiomics outperforms static texture analysis in predicting overall survival in pediatric PDMGs, and to the best of our knowledge, this is the first study to investigate the prognostic utility of delta-radiomics in this population. Evidence is provided that delta radiomics can serve as a non-invasive marker for early prognostic stratification in pediatric PDMGs. Validation in larger, multi-center cohorts is required to confirm its clinical utility.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prognostic role of delta radiomics in pediatric pontine diffuse midline gliomas

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月11日

查看全文
  • Erhan Bıyıklı,
  • Tahsin Aybal,
  • Bulent Aslan,
  • Dilek Gul,
  • Nursah Eker,
  • Beste Melek Atasoy,
  • Ayse Gulnur Tokuc,
  • Feyyaz Baltacıoglu

摘要

Purpose

Pontine diffuse midline gliomas (PDMGs) are among the most lethal pediatric brain tumors with a median survival of approximately one year. Reliable prognostic markers are needed to guide treatment strategies and inform families. Our study aims to investigate the prognostic utility of delta-radiomic features in PDMGs.

Materials and methods

We retrospectively analyzed 35 pediatric patients with PDMG diagnosed between 2012 and 2020, all treated with radiotherapy plus concomitant and adjuvant temozolomide. Pre- and post-treatment MRI (T1-weighted, T2-weighted, and ADC maps) were subjected to manual segmentation and texture feature extraction using MaZda software. Delta radiomics features were calculated as ratios between post- and pre-treatment values. Diagnostic performance for predicting survival below or above 12 months was assessed using ROC analysis, while overall survival was further evaluated with Kaplan–Meier and Cox regression models.

Results

Median overall survival was 13 months (range: 6–69). Among baseline features, only sum average from non-contrast T1 was significant, with lower values (indicating higher heterogeneity) associated with shorter OS. In the post-radiotherapy setting, sum entropy from T1 images emerged as an independent prognostic predictor, with higher values correlating with longer OS. Delta radiomics parameters, particularly sum entropy derived from T1 and T2 sequences, yielded higher AUC values than single post-treatment features, suggesting superior prognostic accuracy.

Conclusion

Our preliminary results indicate that delta-radiomics outperforms static texture analysis in predicting overall survival in pediatric PDMGs, and to the best of our knowledge, this is the first study to investigate the prognostic utility of delta-radiomics in this population. Evidence is provided that delta radiomics can serve as a non-invasive marker for early prognostic stratification in pediatric PDMGs. Validation in larger, multi-center cohorts is required to confirm its clinical utility.